Diabetic retinopathy: An update on treatment.
Diabetic retinopathy is a progressive disease that results from vascular injury due to chronic hyperglycemia. It is the leading cause of blindness in working-age adults in the US and is usually asymptomatic until late stages. Treatment with laser photocoagulation is effective at preventing severe vision loss; thus, diabetic patients should be referred for regular screening by an ophthalmologist. New inhibitors of vascular endothelial growth factor may provide targeted nonsurgical treatment to improve vision in diabetic retinopathy.
Fante
Ryan J
RJ
University of Colorado School of Medicine, Denver, 80045, USA.
Durairaj
Vikram D
VD
Oliver
Scott C N
SC
D000328:Adult; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D003930:Diabetic Retinopathy / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D007267:Injections; D017075:Laser Coagulation / Q000379:methods*; D014821:Vitrectomy / Q000379:methods*; D014822:Vitreous Body
D020533:Angiogenesis Inhibitors